Skip to main content
. 2021 Oct 29;25(2):401–410. doi: 10.1007/s10120-021-01258-6

Fig. 2.

Fig. 2

Overall survival curves for patients subdivided by pretreatment tumor markers. Figure 1a CEA (p = 0.002); Fig. 1b CA 19-9 (p < 0.001); Fig. 1c combination CEA and CA 19-9 (p < 0.001)